Orgenesis subsidiary Theracell enters $1 million convertible loan agreement
PositiveFinancial Markets

Orgenesis' subsidiary, Theracell, has secured a $1 million convertible loan agreement, marking a significant step in its financial strategy. This funding will enable Theracell to advance its innovative therapies and expand its operations, which is crucial for the company's growth and development in the competitive biotech sector.
— Curated by the World Pulse Now AI Editorial System